Clinical Trial Update: Efficacy of taVNS Versus Sham Stimulation in Reduing Depressive Symptoms in Patients With Epilepsy: a Multi-center, Double-blinded, Randomized, 20-week, Parallel-arm, Superiority Study [NA]

View source ↗

Summary

A multi-center, double-blind trial compares taVNS to sham to evaluate reduction of depressive symptoms in patients with epilepsy over 20 weeks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Epilepsy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Depressive Symptoms in Patients With Epilepsy | NA | Status: ACTIVE_NOT_RECRUITING